Blood Assurance needs donations all year, but the "100 Deadliest Days of Summer" calls for even more trauma care and a higher need for donors. To encourage donations, Blood Assurance is hosting ...

The FDA recently cleared the Lumipulse blood test for early diagnosis of Alzheimer's disease in ... More people 55 and over with memory loss. The noninvasive Lumipulse blood test measures the leve ...

US regulators have approved the first blood test to help diagnose Alzheimer’s disease, potentially making it easier to find and treat patients with the mind-robbing disease that affects nearly 7 ...

(Bloomberg) -- US regulators have approved the first blood test to help diagnose Alzheimer’s disease, potentially making it easier to find and treat patients with the mind-robbing disease that ...

WASHINGTON — U.S. health officials on Friday endorsed the first blood test that can help diagnose Alzheimer’s and identify patients who may benefit from drugs that can modestly slow the ...

The test, developed by Fujirebio Diagnostics, measures the ratio of two proteins in the blood. The ratio is correlated with amyloid plaques in the brain—a hallmark of Alzheimer's that, until now ...

May 16 (UPI) --The U.S. Food and Drug Administration on Friday approved a new blood test for the early detection of Alzheimer's disease in patients beginning to show cognitive decline. Fujirebio ...

The FDA said it has issued its first official green light for a blood test to help diagnose Alzheimer’s disease, adding that it can help reduce the need for invasive samples or expensive PET scans.

We're now closer to being able to diagnose the most common form of dementia with a simple test. The Food and Drug Administration on May 16 said it cleared the first blood test for Alzheimer's disease.

The FDA said the results of the newly cleared blood test must be assessed in conjunction with other clinical information from a patient. “Alzheimer’s disease impacts too many people, more than ...

Fujirebio Diagnostics designed the blood test to help detect Alzheimer’s disease early, when interventions are more effective, president and CEO Monte Wiltse said in a news release last year ...

A blood test intended to detect colorectal cancer performed well in a clinical study, a step towards expanding options for screening the potentially deadly disease. Published in the New England ...